Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis

NCT00758446 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: BLX-028914
DRUG: BLX-028914
DRUG: placebo

Sponsor

Dart NeuroScience, LLC

Collaborators

[object Object]